Evidence map›Paper›PMID 32091180›Full record

ArticleCytometry. Part A : the journal of the International Society for Analytical Cytology2020

Label-Free Leukemia Monitoring by Computer Vision.

Minh Doan, Marian Case, Dino Masic, Holger Hennig, Claire McQuin, Juan Caicedo, Shantanu Singh, Allen Goodman, Olaf Wolkenhauer, Huw D Summers and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Cytometry. Part A : the journal of the International Society for Analytical Cytology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 3 pooled it
9.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 3 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Assessment of stored red blood cells through lab-on-a-chip technologies for precision transfusion medicine.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  16. Article
  17. Article
  18. Artificial intelligence in imaging flow cytometry.Frontiers in bioinformatics · 2023
    Article
  19. A New Image for Cell Sorting.The New England journal of medicine · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 3 countries.

Minh DoanImaging Platform, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
Marian CaseNorthern Institute for Cancer Research, Newcastle University, UK.
Dino MasicNorthern Institute for Cancer Research, Newcastle University, UK.
Holger HennigImaging Platform, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
Claire McQuinImaging Platform, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
Juan CaicedoImaging Platform, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
Shantanu SinghImaging Platform, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.ORCID 0000-0003-3150-3025
Allen GoodmanImaging Platform, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
Olaf WolkenhauerDepartment of Systems Biology & Bioinformatics, University of Rostock, Rostock, Germany.
Huw D SummersCollege of Engineering, Swansea University, Bay Campus, Swansea, SA1 8EN, UK.
David JamiesonNorthern Institute for Cancer Research, Newcastle University, UK.
Frederik V DelftNorthern Institute for Cancer Research, Newcastle University, UK.
Andrew FilbyFlow Cytometry Core Facility. Innovation, Methodology and Application Research Theme, Biosciences Institute, Newcastle University, NE2 4HH, UK.
Anne E CarpenterImaging Platform, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.ORCID 0000-0003-1555-8261
Paul ReesImaging Platform, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
Julie IrvingNorthern Institute for Cancer Research, Newcastle University, UK.
Broad Institute · USNewcastle University · GBSwansea University · GBUniversity of Rostock · DE

Funding

Extracting rich information from biological imagesR35GM122547 · NIGMS · BROAD INSTITUTE, INC. · PI Anne E. Carpenter · 2017 to 2026
$6.2M
Biotechnology and Biological Sciences Research Council BB/P026818/1Blood Cancer UK 11007Division of Biological Infrastructure BB/N005163/1NIGMS NIH HHS R35 GM122547
6 · The paper itself

Abstract

Acute lymphoblastic leukemia (ALL) is the most common childhood cancer. While there are a number of well-recognized prognostic biomarkers at diagnosis, the most powerful independent prognostic factor is the response of the leukemia to induction chemotherapy (Campana and Pui: Blood 129 (2017) 1913-1918). Given the potential for machine learning to improve precision medicine, we tested its capacity to monitor disease in children undergoing ALL treatment. Diagnostic and on-treatment bone marrow samples were labeled with an ALL-discriminating antibody combination and analyzed by imaging flow cytometry. Ignoring the fluorescent markers and using only features extracted from bright-field and dark-field cell images, a deep learning model was able to identify ALL cells at an accuracy of >88%. This antibody-free, single cell method is cheap, quick, and could be adapted to a simple, laser-free cytometer to allow automated, point-of-care testing to detect slow early responders. Adaptation to other types of leukemia is feasible, which would revolutionize residual disease monitoring. © 2020 The Authors. Cytometry Part A published by Wiley Periodicals, Inc. on behalf of International Society for Advancement of Cytometry.

Indexed as

LeukemiaMachine LearningChildComputersFlow CytometryHumansNeoplasm, Residualcomputer visiondeep learningimaging flow cytometrylabel-freeleukemiamachine learningneural networks

Identifiers

PMID32091180
PMCPMC7213640
OpenAlexW3007431292

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.